TGFB1 and breast carcinoma: Interestingly, the Kaplan Meier analysis of a large cohort of breast cancer patients (n = 2,976) integrated by Győrffy [38] (available at https://kmplot.com/analysis/index.php?p=service&cancer=breast_rnaseq_gse96058) revealed that high TGFB1 levels are associated with a better prognosis, but only in luminal A patients (Figure S10).